TRIM54 and hepatocellular carcinoma: These data further supported the notion that overexpression of TRIM54 in HCC reduces Axin1 expression and activates Wnt/β-catenin signaling, ultimately leading to tumorigenesis and metastasis and poor clinical outcomes for human HCC (Figure 7C).